Saturday , October 16 2021

Glaxosmithkline Consumer Healthcare gets shareholders’ nod for merger with HUL

Glaxosmithkline Consumer Healthcare has received approval from its shareholders for merger with Hindustan Unilever (HUL). The company has received 99.99 percent votes in favour of the scheme of amalgamation among the company and HUL in the National Company Law Tribunal-convened meeting of the equity shareholders on June 1, 2019.

Glaxosmithkline Consumer Healthcare’s core business is manufacturing of health drinks under the brand Horlicks.

Please share this news
<div id="taboola-below-article-thumbnails"></div>
<script type="text/javascript">
  window._taboola = window._taboola || [];
    mode: 'thumbnails-a',
    container: 'taboola-below-article-thumbnails',
    placement: 'Below Article Thumbnails',
    target_type: 'mix'